MitoChem Therapeutics develops treatments to address the effects of mitochondrial dysfunction in neurodegenerative, aging, and disease.
MitoChem Therapeutics develops treatments to address the effects of mitochondrial dysfunction in neurodegenerative disease.It was founded by Craig Beeson and Bärbel Rohrer in Charleston, South Carolina.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 2, 2012 | Seed | $2M | 1 | Foundation Fighting Blindness | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Foundation Fighting Blindness | Yes | Seed |